NCT01361412已完成2 期
An Optional Research Study to Identify Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy in Subjects Already Enrolled in Clinical Study TR002
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 2
- 主要终点
- Identification of potential plasma biomarkers of response to peptide immunotherapy
研究概览
简要总结
The aim of the study is to identify changes in potential biomarkers after peptide immunotherapy for that may subsequently be developed as biomarkers that correlate with clinical efficacy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Enrolled in study TR002 but have not yet commenced dosing
排除标准
- •None; no criteria additional to TR002 exclusion criteria are applicable to this study
结局指标
主要结局
Identification of potential plasma biomarkers of response to peptide immunotherapy
时间窗: 6 months after start of dosing
Blood samples derived from the study will be submitted for proteomics analyses aimed at the identification of one or more plasma proteins whose concentration over the course of the study varies in relation to the treatment administered. The outcome will be determined on the basis of measurements from samples collected over a period commencing prior to treatment and ending 6 months following treatmen
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Brain Connectivity in Neurodevelopmental Disorders in Response to TreatmentAutism Spectrum DisordersPsychosisFragile X SyndromeNCT01364818University of North Carolina, Chapel Hill25
已完成
2 期
BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerLung CancerNCT01263782M.D. Anderson Cancer Center64
Unknown
不适用
Prognostic Biomarker for CRCColorectal CancerNCT03928652Sixth Affiliated Hospital, Sun Yat-sen University1,050
已完成
不适用
Clinical effects and biomarkers of biological agents on asthmaBronchial asthmaasthmaJPRN-jRCT1031190033MORI AKIO12
已完成
4 期
Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel DiseaseInflammatory Bowel DiseasesUlcerative ColitisCrohn DiseaseNCT03885713Fundación de Investigación Biomédica - Hospital Universitario de La Princesa180